Search Results 531-540 of 13264 for Assay

  1. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

    A positive serum free lite assay is acceptable. ECOG performance status of 0 - 2. Meet all institutional requirements for autologous stem cell ...

  2. Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer - Mayo Clinic

    IHC assay must show a strong positive (3+) staining score. NOTE: ductal carcinoma in situ (DCIS) components should not be counted in the determination of ...

  3. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma - Mayo Clinic

    Undetectable viral load per standard of care assay;; Receiving antiretroviral therapy (ART/HAART) for at least 4 weeks prior to study enrollment, and have ...

  4. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    - If a screening assay against pooled HLA antigens is used, positive results ... concentration on the single antigen assays. Donor anti- recipient

  5. Blood Transfusion Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare a restrictive versus a more liberal transfusion strategy in high risk patients having cardiac surgery. Laboratory Assay ...

  6. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    A negative QuantiFERON® TB-Gold In-Tube test (or centrally reported equivalent assay) at screening; AND; A chest radiograph (views as per local guidelines) ...

  7. Ampullary Cancer Clinical Trials

    GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

  8. Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    - Serum free light chains (FLC) assay: Involved FLC assay ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65) - Measurable bone or ...

  9. Mayo Clinic expert answers questions about COVID-19 testing

    I think the prudent thing to do would be to contact your physician and determine what assays they have available. Related posts: "Mayo Clinic Laboratories ...

  10. A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma - Mayo Clinic

    About this study. Primary Objective: - Part A: To evaluate the safety of SAR650984 (isatuximab) in patients with relapsed/refractory multiple myeloma (RRMM) ...